Centric Wealth Management Gilead Sciences, Inc. Transaction History

Centric Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $184,282 - $209,981	-3,253 Closed	0 $0
Q3 2020 Oct 05, 2020	SELL	$62.1 - $78.08 $746,628 - $938,755	-12,023 Reduced 78.71%	3,253 $200,000
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $869,743 - $1.01 Million	12,023 Added 369.6%	15,276 $1.18 Million
Q1 2020 Apr 08, 2020	SELL	$62.63 - $80.22 $473,169 - $606,062	-7,555 Reduced 69.9%	3,253 $200,000
Q4 2019 Jan 06, 2020	BUY	$61.62 - $67.78 $465,539 - $512,077	7,555 Added 232.25%	10,808 $702,000
Q3 2019 Oct 03, 2019	BUY	$62.51 - $69.0 $3,125 - $3,450	50 Added 1.56%	3,253 $200,000
Q2 2019 Jul 08, 2019	BUY	$61.87 - $69.38 $198,169 - $222,224	3,203 New	3,203 $216,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Centric Wealth Management with notifications on news.